-
1
-
-
63849339897
-
Could inflammatory markers help diagnose nonalcoholic steatohepatitis
-
Tarantino, G.; Conca, P.; Pasanisi, F.; Ariello, M.; Mastrolia, M.; Arena, A.; Tarantino, M.; Scopacasa, F.; Vecchione, R. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur. J. Gastroenterol. Hepatol. 2009, 21, 504–511.
-
(2009)
Eur. J. Gastroenterol. Hepatol
, vol.21
, pp. 504-511
-
-
Tarantino, G.1
Conca, P.2
Pasanisi, F.3
Ariello, M.4
Mastrolia, M.5
Arena, A.6
Tarantino, M.7
Scopacasa, F.8
Vecchione, R.9
-
2
-
-
0037382786
-
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
-
Marchesini, G.; Bugianesi, E.; Forlani, G.; Cerrelli, F.; Lenzi, M.; Manini, R.; Natale, S.; Vanni, E.; Villanova, N.; Melchionda, N. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37, 917–923.
-
(2003)
Hepatology
, vol.37
, pp. 917-923
-
-
Marchesini, G.1
Bugianesi, E.2
Forlani, G.3
Cerrelli, F.4
Lenzi, M.5
Manini, R.6
Natale, S.7
Vanni, E.8
Villanova, N.9
Melchionda, N.10
-
3
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
-
Adams, L.A.; Lymp, J.F.; St Sauver, J.; Sanderson, S.O.; Lindor, K.D.; Feldstein, A.; Angulo, P. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005, 129, 113–121.
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
St Sauver, J.3
Sanderson, S.O.4
Lindor, K.D.5
Feldstein, A.6
Angulo, P.7
-
4
-
-
80555136061
-
Meta-analysis: Natural history of non-alcoholic fatty liver disease (nafld) and diagnostic accuracy of non-invasive tests for liver disease severity
-
Musso, G.; Gambino, R.; Cassader, M.; Pagano, G. Meta-analysis: Natural history of non-alcoholic fatty liver disease (nafld) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 2011, 43, 617–649.
-
(2011)
Ann. Med
, vol.43
, pp. 617-649
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
Pagano, G.4
-
5
-
-
0034799113
-
Ninety patients with nonalcoholic steatohepatitis: Insulin resistance, familial tendency, and severity of disease
-
Willner, I.R.; Waters, B.; Patil, S.R.; Reuben, A.; Morelli, J.; Riely, C.A. Ninety patients with nonalcoholic steatohepatitis: Insulin resistance, familial tendency, and severity of disease. Am. J. Gastroenterol. 2001, 96, 2957–2961.
-
(2001)
Am. J. Gastroenterol
, vol.96
, pp. 2957-2961
-
-
Willner, I.R.1
Waters, B.2
Patil, S.R.3
Reuben, A.4
Morelli, J.5
Riely, C.A.6
-
6
-
-
84883763886
-
Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up
-
Zelber-Sagi, S.; Lotan, R.; Shibolet, O.; Webb, M.; Buch, A.; Nitzan-Kaluski, D.; Halpern, Z.; Santo, E.; Oren, R. Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. Liver Int. 2013, 33, 1406–1412.
-
(2013)
Liver Int
, vol.33
, pp. 1406-1412
-
-
Zelber-Sagi, S.1
Lotan, R.2
Shibolet, O.3
Webb, M.4
Buch, A.5
Nitzan-Kaluski, D.6
Halpern, Z.7
Santo, E.8
Oren, R.9
-
7
-
-
0016761686
-
Fatty liver: Biochemical and clinical considerations
-
Hoyumpa, A.M., Jr.; Greene, H.L.; Dunn, G.D.; Schenker, S. Fatty liver: Biochemical and clinical considerations. Am. J. Dig. Dis. 1975, 20, 1142–1170.
-
(1975)
Am. J. Dig. Dis
, vol.20
, pp. 1142-1170
-
-
Hoyumpa, A.M.1
Greene, H.L.2
Dunn, G.D.3
Schenker, S.4
-
8
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
Kleiner, D.E.; Brunt, E.M.; Van Natta, M.; Behling, C.; Contos, M.J.; Cummings, O.W.; Ferrell, L.D.; Liu, Y.C.; Torbenson, M.S.; Unalp-Arida, A., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313–1321.
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
Ferrell, L.D.7
Liu, Y.C.8
Torbenson, M.S.9
Unalp-Arida, A.10
-
9
-
-
0141532275
-
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the ppar-gamma ligand rosiglitazone
-
Neuschwander-Tetri, B.A.; Brunt, E.M.; Wehmeier, K.R.; Oliver, D.; Bacon, B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the ppar-gamma ligand rosiglitazone. Hepatology 2003, 38, 1008–1017.
-
(2003)
Hepatology
, vol.38
, pp. 1008-1017
-
-
Neuschwander-Tetri, B.A.1
Brunt, E.M.2
Wehmeier, K.R.3
Oliver, D.4
Bacon, B.R.5
-
10
-
-
12144259379
-
Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population
-
Szczepaniak, L.S.; Nurenberg, P.; Leonard, D.; Browning, J.D.; Reingold, J.S.; Grundy, S.; Hobbs, H.H.; Dobbins, R.L. Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 2005, 288, E462–E468.
-
(2005)
Am. J. Physiol. Endocrinol. Metab
, vol.288
, pp. E462-E468
-
-
Szczepaniak, L.S.1
Nurenberg, P.2
Leonard, D.3
Browning, J.D.4
Reingold, J.S.5
Grundy, S.6
Hobbs, H.H.7
Dobbins, R.L.8
-
11
-
-
33845315534
-
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in asian-indian men
-
Petersen, K.F.; Dufour, S.; Feng, J.; Befroy, D.; Dziura, J.; Dalla Man, C.; Cobelli, C.; Shulman, G.I. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in asian-indian men. Proc. Natl. Acad. Sci. USA 2006, 103, 18273–18277.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 18273-18277
-
-
Petersen, K.F.1
Dufour, S.2
Feng, J.3
Befroy, D.4
Dziura, J.5
Dalla Man, C.6
Cobelli, C.7
Shulman, G.I.8
-
12
-
-
42949178538
-
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects
-
Korenblat, K.M.; Fabbrini, E.; Mohammed, B.S.; Klein, S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008, 134, 1369–1375.
-
(2008)
Gastroenterology
, vol.134
, pp. 1369-1375
-
-
Korenblat, K.M.1
Fabbrini, E.2
Mohammed, B.S.3
Klein, S.4
-
13
-
-
0037221394
-
Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States
-
Ruhl, C.E.; Everhart, J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003, 124, 71–79.
-
(2003)
Gastroenterology
, vol.124
, pp. 71-79
-
-
Ruhl, C.E.1
Everhart, J.E.2
-
14
-
-
10644220306
-
Prevalence of hepatic steatosis in an urban population in the united states: Impact of ethnicity.
-
Browning, J.D.; Szczepaniak, L.S.; Dobbins, R.; Nuremberg, P.; Horton, J.D.; Cohen, J.C.; Grundy, S.M.; Hobbs, H.H. Prevalence of hepatic steatosis in an urban population in the united states: Impact of ethnicity. Hepatology 2004, 40, 1387–1395.
-
(2004)
Hepatology
, vol.40
, pp. 1387-1395
-
-
Browning, J.D.1
Szczepaniak, L.S.2
Dobbins, R.3
Nuremberg, P.4
Horton, J.D.5
Cohen, J.C.6
Grundy, S.M.7
Hobbs, H.H.8
-
15
-
-
84882862678
-
Common genetic variants and nonalcoholic fatty liver disease
-
Browning, J.D. Common genetic variants and nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2013, 11, 1191–1193.
-
(2013)
Clin. Gastroenterol. Hepatol
, vol.11
, pp. 1191-1193
-
-
Browning, J.D.1
-
16
-
-
84880245463
-
Prevalence of nonalcoholic fatty liver disease in the united states: The third national health and nutrition examination survey, 1988–1994
-
Lazo, M.; Hernaez, R.; Eberhardt, M.S.; Bonekamp, S.; Kamel, I.; Guallar, E.; Koteish, A.; Brancati, F.L.; Clark, J.M. Prevalence of nonalcoholic fatty liver disease in the united states: The third national health and nutrition examination survey, 1988–1994. Am. J. Epidemiol. 2013, 178, 38–45.
-
(2013)
Am. J. Epidemiol
, vol.178
, pp. 38-45
-
-
Lazo, M.1
Hernaez, R.2
Eberhardt, M.S.3
Bonekamp, S.4
Kamel, I.5
Guallar, E.6
Koteish, A.7
Brancati, F.L.8
Clark, J.M.9
-
18
-
-
34247605492
-
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
-
Targher, G.; Bertolini, L.; Padovani, R.; Rodella, S.; Tessari, R.; Zenari, L.; Day, C.; Arcaro, G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007, 30, 1212–1218.
-
(2007)
Diabetes Care
, vol.30
, pp. 1212-1218
-
-
Targher, G.1
Bertolini, L.2
Padovani, R.3
Rodella, S.4
Tessari, R.5
Zenari, L.6
Day, C.7
Arcaro, G.8
-
19
-
-
57749183469
-
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
-
Leite, N.C.; Salles, G.F.; Araujo, A.L.; Villela-Nogueira, C.A.; Cardoso, C.R. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 2009, 29, 113–119.
-
(2009)
Liver Int
, vol.29
, pp. 113-119
-
-
Leite, N.C.1
Salles, G.F.2
Araujo, A.L.3
Villela-Nogueira, C.A.4
Cardoso, C.R.5
-
20
-
-
85028624291
-
High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels
-
Portillo Sanchez, P.; Bril, F.; Maximos, M.; Lomonaco, R.; Biernacki, D.; Orsak, B.; Subbarayan, S.; Webb, A.; Hecht, J.; Cusi, K. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. J. Clin. Endocrinol. Metab. 2014, doi:10.1210/jc.2014-2739.
-
(2014)
J. Clin. Endocrinol. Metab
-
-
Portillo Sanchez, P.1
Bril, F.2
Maximos, M.3
Lomonaco, R.4
Biernacki, D.5
Orsak, B.6
Subbarayan, S.7
Webb, A.8
Hecht, J.9
Cusi, K.10
-
21
-
-
0002867561
-
Energy metabolism
-
3rd ed.; Arias, I.M.; Boyer, J.L.; Fausto, N.; Jakoby, W.B.; Schachter, D.A.; Shafritz, D.A., Eds.; Raven Press, Ltd.: New York, NY, USA
-
Seifter, S.; Englard, S. Energy metabolism. In The Liver: Biology and Pathobiology, 3rd ed.; Arias, I.M.; Boyer, J.L.; Fausto, N.; Jakoby, W.B.; Schachter, D.A.; Shafritz, D.A., Eds.; Raven Press, Ltd.: New York, NY, USA, 1994; pp. 323–364.
-
(1994)
The Liver: Biology and Pathobiology
, pp. 323-364
-
-
Seifter, S.1
Englard, S.2
-
22
-
-
0025768055
-
The role of the liver in metabolic homeostasis: Implications for inborn errors of metabolism
-
Van den Berghe, G. The role of the liver in metabolic homeostasis: Implications for inborn errors of metabolism. J. Inherit. Metab. Dis. 1991, 14, 407–420.
-
(1991)
J. Inherit. Metab. Dis
, vol.14
, pp. 407-420
-
-
Van Den Berghe, G.1
-
24
-
-
0009805718
-
-
Cherrington, A.D. Control of glucose production in vivo by insulin and glucagon. In, Jefferson, L.S.; Cherrington, A.D., Eds.; American Physiological Society/Oxford University Press: New York, NY, USA
-
Cherrington, A.D. Control of glucose production in vivo by insulin and glucagon. In The Endocrine Pancreas and Regulation of Metabolism (Handbook of Physiology, Section 7: The Endocrine System, Volume ii); Jefferson, L.S.; Cherrington, A.D., Eds.; American Physiological Society/Oxford University Press: New York, NY, USA, 2001; Volume 2, pp. 759–785.
-
(2001)
The Endocrine Pancreas and Regulation of Metabolism (Handbook of Physiology, Section 7: The Endocrine System, Volume Ii)
, vol.2
, pp. 759-785
-
-
-
25
-
-
0002831590
-
Carbohydrates and the liver
-
3rd ed.; Rodés, J.; Benhamou, J.-P., Blei, A.T., Reichen, J., Rizzetto, M., Eds.; Blackwell Publishing: Malden, MA, USA
-
Boden, G. Carbohydrates and the liver. In Textbook of Hepatology: From Basic Science to Clinical Practice, 3rd ed.; Rodés, J.; Benhamou, J.-P., Blei, A.T., Reichen, J., Rizzetto, M., Eds.; Blackwell Publishing: Malden, MA, USA, 2007; pp. 129–133.
-
(2007)
Textbook of Hepatology: From Basic Science to Clinical Practice
, pp. 129-133
-
-
Boden, G.1
-
26
-
-
4043101702
-
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis
-
Gastaldelli, A.; Miyazaki, Y.; Pettiti, M.; Buzzigoli, E.; Mahankali, S.; Ferrannini, E.; DeFronzo, R.A. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J. Clin. Endocrinol. Metab. 2004, 89, 3914–3921.
-
(2004)
J. Clin. Endocrinol. Metab
, vol.89
, pp. 3914-3921
-
-
Gastaldelli, A.1
Miyazaki, Y.2
Pettiti, M.3
Buzzigoli, E.4
Mahankali, S.5
Ferrannini, E.6
Defronzo, R.A.7
-
27
-
-
0023576840
-
Use of the splanchnic/hepatic balance technique in the study of glucose metabolism. Baillieres Clin
-
DeFronzo, R.A. Use of the splanchnic/hepatic balance technique in the study of glucose metabolism. Baillieres Clin. Endocrinol. Metab. 1987, 1, 837–862.
-
(1987)
Endocrinol. Metab
, vol.1
, pp. 837-862
-
-
Defronzo, R.A.1
-
28
-
-
0036312905
-
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
-
Seppala-Lindroos, A.; Vehkavaara, S.; Hakkinen, A.M.; Goto, T.; Westerbacka, J.; Sovijarvi, A.; Halavaara, J.; Yki-Jarvinen, H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 2002, 87, 3023–3028.
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, pp. 3023-3028
-
-
Seppala-Lindroos, A.1
Vehkavaara, S.2
Hakkinen, A.M.3
Goto, T.4
Westerbacka, J.5
Sovijarvi, A.6
Halavaara, J.7
Yki-Jarvinen, H.8
-
29
-
-
0035084699
-
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
-
Sanyal, A.J.; Campbell-Sargent, C.; Mirshahi, F.; Rizzo, W.B.; Contos, M.J.; Sterling, R.K.; Luketic, V.A.; Shiffman, M.L.; Clore, J.N. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120, 1183–1192.
-
(2001)
Gastroenterology
, vol.120
, pp. 1183-1192
-
-
Sanyal, A.J.1
Campbell-Sargent, C.2
Mirshahi, F.3
Rizzo, W.B.4
Contos, M.J.5
Sterling, R.K.6
Luketic, V.A.7
Shiffman, M.L.8
Clore, J.N.9
-
30
-
-
20944450486
-
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms
-
Bugianesi, E.; Gastaldelli, A.; Vanni, E.; Gambino, R.; Cassader, M.; Baldi, S.; Ponti, V.; Pagano, G.; Ferrannini, E.; Rizzetto, M. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms. Diabetologia 2005, 48, 634–642.
-
(2005)
Diabetologia
, vol.48
, pp. 634-642
-
-
Bugianesi, E.1
Gastaldelli, A.2
Vanni, E.3
Gambino, R.4
Cassader, M.5
Baldi, S.6
Ponti, V.7
Pagano, G.8
Ferrannini, E.9
Rizzetto, M.10
-
31
-
-
84905564642
-
Independent association of liver fat accumulation with insulin resistance
-
Yatsuya, H.; Nihashi, T.; Li, Y.; Hotta, Y.; Matsushita, K.; Muramatsu, T.; Otsuka, R.; Matsunaga, M.; Yamashita, K.; Wang, C. et al. Independent association of liver fat accumulation with insulin resistance. Obes. Res. Clin. Pract. 2014, 8, e350–e355.
-
(2014)
Obes. Res. Clin. Pract.
, vol.8
, pp. e350-e355
-
-
Yatsuya, H.1
Nihashi, T.2
Li, Y.3
Hotta, Y.4
Matsushita, K.5
Muramatsu, T.6
Otsuka, R.7
Matsunaga, M.8
Yamashita, K.9
Wang, C.10
-
32
-
-
70349326750
-
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
-
Fabbrini, E.; Magkos, F.; Mohammed, B.S.; Pietka, T.; Abumrad, N.A.; Patterson, B.W.; Okunade, A.; Klein, S. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. USA 2009, 106, 15430–15435.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 15430-15435
-
-
Fabbrini, E.1
Magkos, F.2
Mohammed, B.S.3
Pietka, T.4
Abumrad, N.A.5
Patterson, B.W.6
Okunade, A.7
Klein, S.8
-
33
-
-
34548787759
-
Metabolic correlates of nonalcoholic fatty liver in women and men
-
Vega, G.L.; Chandalia, M.; Szczepaniak, L.S.; Grundy, S.M. Metabolic correlates of nonalcoholic fatty liver in women and men. Hepatology 2007, 46, 716–722.
-
(2007)
Hepatology
, vol.46
, pp. 716-722
-
-
Vega, G.L.1
Chandalia, M.2
Szczepaniak, L.S.3
Grundy, S.M.4
-
34
-
-
84922208434
-
Metabolically normal obese people are protected from adverse effects following weight gain
-
Fabbrini, E.; Yoshino, J.; Yoshino, M.; Magkos, F.; Tiemann Luecking, C.; Samovski, D.; Fraterrigo, G.; Okunade, A.L.; Patterson, B.W.; Klein, S. Metabolically normal obese people are protected from adverse effects following weight gain. J. Clin. Investig. 2015, 125, 787–795.
-
(2015)
J. Clin. Investig
, vol.125
, pp. 787-795
-
-
Fabbrini, E.1
Yoshino, J.2
Yoshino, M.3
Magkos, F.4
Tiemann Luecking, C.5
Samovski, D.6
Fraterrigo, G.7
Okunade, A.L.8
Patterson, B.W.9
Klein, S.10
-
35
-
-
84920627017
-
Influence of liver triglycerides on suppression of glucose production by insulin in men
-
Jin, E.S.; Szuszkiewicz-Garcia, M.; Browning, J.D.; Baxter, J.D.; Abate, N.; Malloy, C.R. Influence of liver triglycerides on suppression of glucose production by insulin in men. J. Clin. Endocrinol. Metab. 2015, 100, 235–243.
-
(2015)
J. Clin. Endocrinol. Metab
, vol.100
, pp. 235-243
-
-
Jin, E.S.1
Szuszkiewicz-Garcia, M.2
Browning, J.D.3
Baxter, J.D.4
Abate, N.5
Malloy, C.R.6
-
36
-
-
3543029821
-
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
-
Samuel, V.T.; Liu, Z.X.; Qu, X.; Elder, B.D.; Bilz, S.; Befroy, D.; Romanelli, A.J.; Shulman, G.I. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 2004, 279, 32345–32353.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 32345-32353
-
-
Samuel, V.T.1
Liu, Z.X.2
Qu, X.3
Elder, B.D.4
Bilz, S.5
Befroy, D.6
Romanelli, A.J.7
Shulman, G.I.8
-
37
-
-
33847404482
-
Inhibition of protein kinase cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease
-
Samuel, V.T.; Liu, Z.X.; Wang, A.; Beddow, S.A.; Geisler, J.G.; Kahn, M.; Zhang, X.M.; Monia, B.P.; Bhanot, S.; Shulman, G.I. Inhibition of protein kinase cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Investig. 2007, 117, 739–745.
-
(2007)
J. Clin. Investig
, vol.117
, pp. 739-745
-
-
Samuel, V.T.1
Liu, Z.X.2
Wang, A.3
Beddow, S.A.4
Geisler, J.G.5
Kahn, M.6
Zhang, X.M.7
Monia, B.P.8
Bhanot, S.9
Shulman, G.I.10
-
38
-
-
0036785633
-
Free fatty acid-induced hepatic insulin resistance: A potential role for protein kinase c-delta
-
Lam, T.K.; Yoshii, H.; Haber, C.A.; Bogdanovic, E.; Lam, L.; Fantus, I.G.; Giacca, A. Free fatty acid-induced hepatic insulin resistance: A potential role for protein kinase c-delta. Am. J. Physiol. Endocrinol. Metab. 2002, 283, E682–E691.
-
(2002)
Am. J. Physiol. Endocrinol. Metab
, vol.283
, pp. E682-E691
-
-
Lam, T.K.1
Yoshii, H.2
Haber, C.A.3
Bogdanovic, E.4
Lam, L.5
Fantus, I.G.6
Giacca, A.7
-
39
-
-
70949092540
-
Schmitz-Peiffer, C. Diverse roles for protein kinase c delta and protein kinase c epsilon in the generation of high-fat-diet-induced glucose intolerance in mice: Regulation of lipogenesis by protein kinase c delta
-
Frangioudakis, G.; Burchfield, J.G.; Narasimhan, S.; Cooney, G.J.; Leitges, M.; Biden, T.J.; Schmitz-Peiffer, C. Diverse roles for protein kinase c delta and protein kinase c epsilon in the generation of high-fat-diet-induced glucose intolerance in mice: Regulation of lipogenesis by protein kinase c delta. Diabetologia 2009, 52, 2616–2620.
-
(2009)
Diabetologia
, vol.52
, pp. 2616-2620
-
-
Frangioudakis, G.1
Burchfield, J.G.2
Narasimhan, S.3
Cooney, G.J.4
Leitges, M.5
Biden, T.J.6
-
40
-
-
79957885392
-
Pkcdelta regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
-
Bezy, O.; Tran, T.T.; Pihlajamaki, J.; Suzuki, R.; Emanuelli, B.; Winnay, J.; Mori, M.A.; Haas, J.; Biddinger, S.B.; Leitges, M. et al. Pkcdelta regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J. Clin. Investig. 2011, 121, 2504–2517.
-
(2011)
J. Clin. Investig.
, vol.121
, pp. 2504-2517
-
-
Bezy, O.1
Tran, T.T.2
Pihlajamaki, J.3
Suzuki, R.4
Emanuelli, B.5
Winnay, J.6
Mori, M.A.7
Haas, J.8
Biddinger, S.B.9
Leitges, M.10
-
41
-
-
84893539480
-
Pkcdelta is activated in the liver of obese zucker rats and mediates diet-induced whole body insulin resistance and hepatocyte cellular insulin resistance
-
Greene, M.W.; Burrington, C.M.; Luo, Y.; Ruhoff, M.S.; Lynch, D.T.; Chaithongdi, N. Pkcdelta is activated in the liver of obese zucker rats and mediates diet-induced whole body insulin resistance and hepatocyte cellular insulin resistance. J. Nutr. Biochem. 2014, 25, 281–288.
-
(2014)
J. Nutr. Biochem
, vol.25
, pp. 281-288
-
-
Greene, M.W.1
Burrington, C.M.2
Luo, Y.3
Ruhoff, M.S.4
Lynch, D.T.5
Chaithongdi, N.6
-
42
-
-
84884860377
-
Non alcoholic fatty liver disease, hepatic insulin resistance and type 2 diabetes
-
Birkenfeld, A.L.; Shulman, G.I. Non alcoholic fatty liver disease, hepatic insulin resistance and type 2 diabetes. Hepatology 2013, 59, 713–723.
-
(2013)
Hepatology
, vol.59
, pp. 713-723
-
-
Birkenfeld, A.L.1
Shulman, G.I.2
-
43
-
-
66149093022
-
Loss of protein kinase cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance
-
Huang, W.; Bansode, R.; Mehta, M.; Mehta, K.D. Loss of protein kinase cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance. Hepatology 2009, 49, 1525–1536.
-
(2009)
Hepatology
, vol.49
, pp. 1525-1536
-
-
Huang, W.1
Bansode, R.2
Mehta, M.3
Mehta, K.D.4
-
44
-
-
84906094949
-
Pkcdelta regulates hepatic triglyceride accumulation and insulin signaling in lepr(db/db) mice. Biochem. Biophys
-
Zhang, J.; Burrington, C.M.; Davenport, S.K.; Johnson, A.K.; Horsman, M.J.; Chowdhry, S.; Greene, M.W. Pkcdelta regulates hepatic triglyceride accumulation and insulin signaling in lepr(db/db) mice. Biochem. Biophys. Res. Commun. 2014, 450, 1619–1625.
-
(2014)
Res. Commun
, vol.450
, pp. 1619-1625
-
-
Zhang, J.1
Burrington, C.M.2
Davenport, S.K.3
Johnson, A.K.4
Horsman, M.J.5
Chowdhry, S.6
Greene, M.W.7
-
45
-
-
84861647226
-
Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects
-
Magkos, F.; Su, X.; Bradley, D.; Fabbrini, E.; Conte, C.; Eagon, J.C.; Varela, J.E.; Brunt, E.M.; Patterson, B.W.; Klein, S. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology 2012, 142, 1444–1446.e2.
-
(2012)
Gastroenterology
, vol.142
, pp. 1444-1446
-
-
Magkos, F.1
Su, X.2
Bradley, D.3
Fabbrini, E.4
Conte, C.5
Eagon, J.C.6
Varela, J.E.7
Brunt, E.M.8
Patterson, B.W.9
Klein, S.10
-
46
-
-
80053627289
-
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
-
Kumashiro, N.; Erion, D.M.; Zhang, D.; Kahn, M.; Beddow, S.A.; Chu, X.; Still, C.D.; Gerhard, G.S.; Han, X.; Dziura, J. et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc. Natl. Acad. Sci. USA 2011, 108, 16381–16385.
-
(2011)
Proc. Natl. Acad. Sci. USA
, vol.108
, pp. 16381-16385
-
-
Kumashiro, N.1
Erion, D.M.2
Zhang, D.3
Kahn, M.4
Beddow, S.A.5
Chu, X.6
Still, C.D.7
Gerhard, G.S.8
Han, X.9
Dziura, J.10
-
47
-
-
4444222570
-
Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity
-
Tripathy, D.; Almgren, P.; Tuomi, T.; Groop, L. Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care 2004, 27, 2204–2210.
-
(2004)
Diabetes Care
, vol.27
, pp. 2204-2210
-
-
Tripathy, D.1
Almgren, P.2
Tuomi, T.3
Groop, L.4
-
48
-
-
84865304883
-
Nuclear receptor ppargamma-regulated monoacylglycerol o-acyltransferase 1 (mgat1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis
-
Lee, Y.J.; Ko, E.H.; Kim, J.E.; Kim, E.; Lee, H.; Choi, H.; Yu, J.H.; Kim, H.J.; Seong, J.K.; Kim, K.S. et al. Nuclear receptor ppargamma-regulated monoacylglycerol o-acyltransferase 1 (mgat1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proc. Natl. Acad. Sci. USA 2012, 109, 13656–13661.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 13656-13661
-
-
Lee, Y.J.1
Ko, E.H.2
Kim, J.E.3
Kim, E.4
Lee, H.5
Choi, H.6
Yu, J.H.7
Kim, H.J.8
Seong, J.K.9
Kim, K.S.10
-
49
-
-
84860280975
-
Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver
-
Hall, A.M.; Kou, K.; Chen, Z.; Pietka, T.A.; Kumar, M.; Korenblat, K.M.; Lee, K.; Ahn, K.; Fabbrini, E.; Klein, S. et al. Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. J. Lipid Res. 2012, 53, 990–999.
-
(2012)
J. Lipid Res
, vol.53
, pp. 990-999
-
-
Hall, A.M.1
Kou, K.2
Chen, Z.3
Pietka, T.A.4
Kumar, M.5
Korenblat, K.M.6
Lee, K.7
Ahn, K.8
Fabbrini, E.9
Klein, S.10
-
50
-
-
84903179316
-
Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice
-
Hall, A.M.; Soufi, N.; Chambers, K.T.; Chen, Z.; Schweitzer, G.G.; McCommis, K.S.; Erion, D.M.; Graham, M.J.; Su, X.; Finck, B.N. Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice. Diabetes 2014, 63, 2284–2296.
-
(2014)
Diabetes
, vol.63
, pp. 2284-2296
-
-
Hall, A.M.1
Soufi, N.2
Chambers, K.T.3
Chen, Z.4
Schweitzer, G.G.5
McCommis, K.S.6
Erion, D.M.7
Graham, M.J.8
Su, X.9
Finck, B.N.10
-
51
-
-
84884860377
-
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes
-
Birkenfeld, A.L.; Shulman, G.I. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 2014, 59, 713–723.
-
(2014)
Hepatology
, vol.59
, pp. 713-723
-
-
Birkenfeld, A.L.1
Shulman, G.I.2
-
52
-
-
84868330086
-
Activation of cannabinoid receptor type 1 (cb1r) disrupts hepatic insulin receptor signaling via cyclic amp-response element-binding protein h (crebh)-mediated induction of lipin1 gene
-
Chanda, D.; Kim, Y.H.; Kim, D.K.; Lee, M.W.; Lee, S.Y.; Park, T.S.; Koo, S.H.; Lee, C.H.; Choi, H.S. Activation of cannabinoid receptor type 1 (cb1r) disrupts hepatic insulin receptor signaling via cyclic amp-response element-binding protein h (crebh)-mediated induction of lipin1 gene. J. Biol. Chem. 2012, 287, 38041–38049.
-
(2012)
J. Biol. Chem
, vol.287
, pp. 38041-38049
-
-
Chanda, D.1
Kim, Y.H.2
Kim, D.K.3
Lee, M.W.4
Lee, S.Y.5
Park, T.S.6
Koo, S.H.7
Lee, C.H.8
Choi, H.S.9
-
53
-
-
84894234845
-
Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World
-
Zhang, X.Q.; Xu, C.F.; Yu, C.H.; Chen, W.X.; Li, Y.M. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol. 2014, 20, 1768–1776.
-
(2014)
J. Gastroenterol
, vol.20
, pp. 1768-1776
-
-
Zhang, X.Q.1
Xu, C.F.2
Yu, C.H.3
Chen, W.X.4
Li, Y.M.5
-
54
-
-
30944451788
-
Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis
-
Wang, D.; Wei, Y.; Pagliassotti, M.J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006, 147, 943–951.
-
(2006)
Endocrinology
, vol.147
, pp. 943-951
-
-
Wang, D.1
Wei, Y.2
Pagliassotti, M.J.3
-
55
-
-
5644231992
-
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
-
Ozcan, U.; Cao, Q.; Yilmaz, E.; Lee, A.H.; Iwakoshi, N.N.; Ozdelen, E.; Tuncman, G.; Gorgun, C.; Glimcher, L.H.; Hotamisligil, G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306, 457–461.
-
(2004)
Science
, vol.306
, pp. 457-461
-
-
Ozcan, U.1
Cao, Q.2
Yilmaz, E.3
Lee, A.H.4
Iwakoshi, N.N.5
Ozdelen, E.6
Tuncman, G.7
Gorgun, C.8
Glimcher, L.H.9
Hotamisligil, G.S.10
-
56
-
-
38649124615
-
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
-
Puri, P.; Mirshahi, F.; Cheung, O.; Natarajan, R.; Maher, J.W.; Kellum, J.M.; Sanyal, A.J. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 2008, 134, 568–576.
-
(2008)
Gastroenterology
, vol.134
, pp. 568-576
-
-
Puri, P.1
Mirshahi, F.2
Cheung, O.3
Natarajan, R.4
Maher, J.W.5
Kellum, J.M.6
Sanyal, A.J.7
-
57
-
-
62749178966
-
Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss
-
Gregor, M.F.; Yang, L.; Fabbrini, E.; Mohammed, B.S.; Eagon, J.C.; Hotamisligil, G.S.; Klein, S. Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 2009, 58, 693–700.
-
(2009)
Diabetes
, vol.58
, pp. 693-700
-
-
Gregor, M.F.1
Yang, L.2
Fabbrini, E.3
Mohammed, B.S.4
Eagon, J.C.5
Hotamisligil, G.S.6
Klein, S.7
-
58
-
-
14644427890
-
Local and systemic insulin resistance resulting from hepatic activation of ikk-beta and nf-kappab
-
Cai, D.; Yuan, M.; Frantz, D.F.; Melendez, P.A.; Hansen, L.; Lee, J.; Shoelson, S.E. Local and systemic insulin resistance resulting from hepatic activation of ikk-beta and nf-kappab. Nat. Med. 2005, 11, 183–190.
-
(2005)
Nat. Med
, vol.11
, pp. 183-190
-
-
Cai, D.1
Yuan, M.2
Frantz, D.F.3
Melendez, P.A.4
Hansen, L.5
Lee, J.6
Shoelson, S.E.7
-
59
-
-
84921559115
-
Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice
-
Yamaguchi, K.; Nishimura, T.; Ishiba, H.; Seko, Y.; Okajima, A.; Fujii, H.; Tochiki, N.; Umemura, A.; Moriguchi, M.; Sumida, Y. et al. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice. Liver Int. 2015, 35, 550–561.
-
(2015)
Liver Int
, vol.35
, pp. 550-561
-
-
Yamaguchi, K.1
Nishimura, T.2
Ishiba, H.3
Seko, Y.4
Okajima, A.5
Fujii, H.6
Tochiki, N.7
Umemura, A.8
Moriguchi, M.9
Sumida, Y.10
-
60
-
-
38649111018
-
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
-
Fabbrini, E.; Mohammed, B.S.; Magkos, F.; Korenblat, K.M.; Patterson, B.W.; Klein, S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008, 134, 424–431.
-
(2008)
Gastroenterology
, vol.134
, pp. 424-431
-
-
Fabbrini, E.1
Mohammed, B.S.2
Magkos, F.3
Korenblat, K.M.4
Patterson, B.W.5
Klein, S.6
-
61
-
-
0035431018
-
Nonalcoholic fatty liver disease: A feature of the metabolic syndrome
-
Marchesini, G.; Brizi, M.; Bianchi, G.; Tomassetti, S.; Bugianesi, E.; Lenzi, M.; McCullough, A.J.; Natale, S.; Forlani, G.; Melchionda, N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001, 50, 1844–1850.
-
(2001)
Diabetes
, vol.50
, pp. 1844-1850
-
-
Marchesini, G.1
Brizi, M.2
Bianchi, G.3
Tomassetti, S.4
Bugianesi, E.5
Lenzi, M.6
McCullough, A.J.7
Natale, S.8
Forlani, G.9
Melchionda, N.10
-
62
-
-
77950864537
-
Getting heavier, younger: Trajectories of obesity over the life course
-
Lee, J.M.; Pilli, S.; Gebremariam, A.; Keirns, C.C.; Davis, M.M.; Vijan, S.; Freed, G.L.; Herman, W.H.; Gurney, J.G. Getting heavier, younger: Trajectories of obesity over the life course. Int. J. Obes. (Lond.) 2010, 34, 614–623.
-
(2010)
Int. J. Obes. (Lond.)
, vol.34
, pp. 614-623
-
-
Lee, J.M.1
Pilli, S.2
Gebremariam, A.3
Keirns, C.C.4
Davis, M.M.5
Vijan, S.6
Freed, G.L.7
Herman, W.H.8
Gurney, J.G.9
-
63
-
-
84920537829
-
The natural course of healthy obesity over 20 years
-
Bell, J.A.; Hamer, M.; Sabia, S.; Singh-Manoux, A.; Batty, G.D.; Kivimaki, M. The natural course of healthy obesity over 20 years. J. Am. Coll. Cardiol. 2015, 65, 101–102.
-
(2015)
J. Am. Coll. Cardiol
, vol.65
, pp. 101-102
-
-
Bell, J.A.1
Hamer, M.2
Sabia, S.3
Singh-Manoux, A.4
Batty, G.D.5
Kivimaki, M.6
-
64
-
-
84907344350
-
Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women
-
Bedogni, G.; Gastaldelli, A.; Tiribelli, C.; Agosti, F.; De Col, A.; Fessehatsion, R.; Sartorio, A. Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women. J. Endocrinol. Investig. 2014, 37, 739–744.
-
(2014)
J. Endocrinol. Investig
, vol.37
, pp. 739-744
-
-
Bedogni, G.1
Gastaldelli, A.2
Tiribelli, C.3
Agosti, F.4
De Col, A.5
Fessehatsion, R.6
Sartorio, A.7
-
65
-
-
84937526881
-
Nonalcoholic steatohepatitis (nash) is associated with a decline in pancreatic beta cell (β-cell) function
-
Siddiqui, M.S.; Cheang, K.L.; Luketic, V.A.; Boyett, S.; Idowu, M.O.; Patidar, K.; Puri, P.; Matherly, S.; Stravitz, R.T.; Sterling, R.K. et al. Nonalcoholic steatohepatitis (nash) is associated with a decline in pancreatic beta cell (β-cell) function. Dig. Dis. Sci. 2015, doi:10.1007/s10620-015-3627-7.
-
(2015)
Dig. Dis. Sci
-
-
Siddiqui, M.S.1
Cheang, K.L.2
Luketic, V.A.3
Boyett, S.4
Idowu, M.O.5
Patidar, K.6
Puri, P.7
Matherly, S.8
Stravitz, R.T.9
Sterling, R.K.10
-
66
-
-
34347235098
-
Sr.; et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing dgat in the liver
-
Monetti, M.; Levin, M.C.; Watt, M.J.; Sajan, M.P.; Marmor, S.; Hubbard, B.K.; Stevens, R.D.; Bain, J.R.; Newgard, C.B.; Farese, R.V., Sr.; et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing dgat in the liver. Cell Metab. 2007, 6, 69–78.
-
(2007)
Cell Metab
, vol.6
, pp. 69-78
-
-
Monetti, M.1
Levin, M.C.2
Watt, M.J.3
Sajan, M.P.4
Marmor, S.5
Hubbard, B.K.6
Stevens, R.D.7
Bain, J.R.8
Newgard, C.B.9
Farese, R.V.10
-
67
-
-
53149101726
-
Thorens, B.; et al. Blocking vldl secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice
-
Minehira, K.; Young, S.G.; Villanueva, C.J.; Yetukuri, L.; Oresic, M.; Hellerstein, M.K.; Farese, R.V., Jr.; Horton, J.D.; Preitner, F.; Thorens, B.; et al. Blocking vldl secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J. Lipid Res. 2008, 49, 2038–2044.
-
(2008)
J. Lipid Res
, vol.49
, pp. 2038-2044
-
-
Minehira, K.1
Young, S.G.2
Villanueva, C.J.3
Yetukuri, L.4
Oresic, M.5
Hellerstein, M.K.6
Farese, R.V.7
Horton, J.D.8
Preitner, F.9
-
68
-
-
24044512596
-
Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production
-
Grefhorst, A.; Hoekstra, J.; Derks, T.G.; Ouwens, D.M.; Baller, J.F.; Havinga, R.; Havekes, L.M.; Romijn, J.A.; Kuipers, F. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289, G592–G598.
-
(2005)
Am. J. Physiol.Gastrointest. Liver Physiol
, vol.289
, pp. G592-G598
-
-
Grefhorst, A.1
Hoekstra, J.2
Derks, T.G.3
Ouwens, D.M.4
Baller, J.F.5
Havinga, R.6
Havekes, L.M.7
Romijn, J.A.8
Kuipers, F.9
-
69
-
-
23044450772
-
Antisense oligonucleotide reduction of dgat2 expression improves hepatic steatosis and hyperlipidemia in obese mice
-
Yu, X.X.; Murray, S.F.; Pandey, S.K.; Booten, S.L.; Bao, D.; Song, X.Z.; Kelly, S.; Chen, S.; McKay, R.; Monia, B.P. et al. Antisense oligonucleotide reduction of dgat2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 2005, 42, 362–371.
-
(2005)
Hepatology
, vol.42
, pp. 362-371
-
-
Yu, X.X.1
Murray, S.F.2
Pandey, S.K.3
Booten, S.L.4
Bao, D.5
Song, X.Z.6
Kelly, S.7
Chen, S.8
McKay, R.9
Monia, B.P.10
-
70
-
-
77953893410
-
Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia
-
Amaro, A.; Fabbrini, E.; Kars, M.; Yue, P.; Schechtman, K.; Schonfeld, G.; Klein, S. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology 2010, 139, 149–153.
-
(2010)
Gastroenterology
, vol.139
, pp. 149-153
-
-
Amaro, A.1
Fabbrini, E.2
Kars, M.3
Yue, P.4
Schechtman, K.5
Schonfeld, G.6
Klein, S.7
-
71
-
-
79960910228
-
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
-
Visser, M.E.; Lammers, N.M.; Nederveen, A.J.; van der Graaf, M.; Heerschap, A.; Ackermans, M.T.; Sauerwein, H.P.; Stroes, E.S.; Serlie, M.J. Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. Diabetologia 2011, 54, 2113–2121.
-
(2011)
Diabetologia
, vol.54
, pp. 2113-2121
-
-
Visser, M.E.1
Lammers, N.M.2
Nederveen, A.J.3
Van Der Graaf, M.4
Heerschap, A.5
Ackermans, M.T.6
Sauerwein, H.P.7
Stroes, E.S.8
Serlie, M.J.9
-
72
-
-
58549108633
-
Storing up trouble: Does accumulation of intramyocellular triglyceride protect skeletal
-
Watt, M.J. Storing up trouble: Does accumulation of intramyocellular triglyceride protect skeletal muscle from insulin resistance? Clin. Exp. Pharmacol. Physiol. 2009, 36, 5–11.
-
(2009)
Clin. Exp. Pharmacol. Physiol
, vol.36
, pp. 5-11
-
-
Watt, M.J.1
-
73
-
-
34250356015
-
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
-
Yamaguchi, K.; Yang, L.; McCall, S.; Huang, J.; Yu, X.X.; Pandey, S.K.; Bhanot, S.; Monia, B.P.; Li, Y.X.; Diehl, A.M. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007, 45, 1366–1374.
-
(2007)
Hepatology
, vol.45
, pp. 1366-1374
-
-
Yamaguchi, K.1
Yang, L.2
McCall, S.3
Huang, J.4
Yu, X.X.5
Pandey, S.K.6
Bhanot, S.7
Monia, B.P.8
Li, Y.X.9
Diehl, A.M.10
-
74
-
-
65549136260
-
Hepatic lipid partitioning and liver damage in
-
Li, Z.Z.; Berk, M.; McIntyre, T.M.; Feldstein, A.E. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: Role of stearoyl-coa desaturase. J. Biol. Chem. 2009, 284, 5637–5644.
-
(2009)
J. Biol. Chem
, vol.284
, pp. 5637-5644
-
-
Li, Z.Z.1
Berk, M.2
McIntyre, T.M.3
Feldstein, A.E.4
-
75
-
-
34547911800
-
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
-
Petersen, K.F.; Dufour, S.; Savage, D.B.; Bilz, S.; Solomon, G.; Yonemitsu, S.; Cline, G.W.; Befroy, D.; Zemany, L.; Kahn, B.B. et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 2007, 104, 12587–12594.
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 12587-12594
-
-
Petersen, K.F.1
Dufour, S.2
Savage, D.B.3
Bilz, S.4
Solomon, G.5
Yonemitsu, S.6
Cline, G.W.7
Befroy, D.8
Zemany, L.9
Kahn, B.B.10
-
76
-
-
84898439031
-
Nonalcoholic fatty liver disease: Molecular mechanisms for the hepatic steatosis
-
Koo, S.H. Nonalcoholic fatty liver disease: Molecular mechanisms for the hepatic steatosis. Clin. Mol. Hepatol. 2013, 19, 210–215.
-
(2013)
Clin. Mol. Hepatol
, vol.19
, pp. 210-215
-
-
Koo, S.H.1
-
77
-
-
33644850802
-
Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis
-
Bradbury, M.W. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G194–G198.
-
(2006)
Am. J. Physiol. Gastrointest. Liver Physiol
, vol.290
, pp. G194-G198
-
-
Bradbury, M.W.1
-
78
-
-
57649214103
-
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (nafld)
-
Musso, G.; Gambino, R.; Cassader, M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (nafld). Prog. Lipid Res. 2009, 48, 1–26.
-
(2009)
Prog. Lipid Res
, vol.48
, pp. 1-26
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
-
79
-
-
84903730104
-
Plasma membrane phospholipase a2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: Implications for nonalcoholic steatohepatitis
-
Stremmel, W.; Staffer, S.; Wannhoff, A.; Pathil, A.; Chamulitrat, W. Plasma membrane phospholipase a2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: Implications for nonalcoholic steatohepatitis. FASEB J. 2014, 28, 3159–3170.
-
(2014)
FASEB J.
, vol.28
, pp. 3159-3170
-
-
Stremmel, W.1
Staffer, S.2
Wannhoff, A.3
Pathil, A.4
Chamulitrat, W.5
-
80
-
-
85047690933
-
Splanchnic lipolysis in human obesity
-
Nielsen, S.; Guo, Z.; Johnson, C.M.; Hensrud, D.D.; Jensen, M.D. Splanchnic lipolysis in human obesity. J. Clin. Investig. 2004, 113, 1582–1588.
-
(2004)
J. Clin. Investig
, vol.113
, pp. 1582-1588
-
-
Nielsen, S.1
Guo, Z.2
Johnson, C.M.3
Hensrud, D.D.4
Jensen, M.D.5
-
81
-
-
35948982608
-
The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome
-
Tarantino, G.; Lobello, R.; Scopacasa, F.; Contaldo, F.; Pasanisi, F.; Cirillo, M.; De Caterina, M.; Conca, P.; Terracciano, D.; Gennarelli, N. et al. The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome. Clin. Investig. Med. 2007, 30, E192–E199.
-
(2007)
Clin. Investig. Med.
, vol.30
, pp. E192-E199
-
-
Tarantino, G.1
Lobello, R.2
Scopacasa, F.3
Contaldo, F.4
Pasanisi, F.5
Cirillo, M.6
De Caterina, M.7
Conca, P.8
Terracciano, D.9
Gennarelli, N.10
-
82
-
-
70349496577
-
Relationship between body fat mass and free fatty acid kinetics in men and women
-
Mittendorfer, B.; Magkos, F.; Fabbrini, E.; Mohammed, B.S.; Klein, S. Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity 2009, 17, 1872–1877.
-
(2009)
Obesity
, vol.17
, pp. 1872-1877
-
-
Mittendorfer, B.1
Magkos, F.2
Fabbrini, E.3
Mohammed, B.S.4
Klein, S.5
-
83
-
-
57949116523
-
Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content
-
Fabbrini, E.; deHaseth, D.; Deivanayagam, S.; Mohammed, B.S.; Vitola, B.E.; Klein, S. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) 2009, 17, 25–29.
-
(2009)
Obesity (Silver Spring)
, vol.17
, pp. 25-29
-
-
Fabbrini, E.1
Dehaseth, D.2
Deivanayagam, S.3
Mohammed, B.S.4
Vitola, B.E.5
Klein, S.6
-
84
-
-
82955239838
-
Excessive hepatic mitochondrial tca cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease
-
Sunny, N.E.; Parks, E.J.; Browning, J.D.; Burgess, S.C. Excessive hepatic mitochondrial tca cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 2011, 14, 804–810.
-
(2011)
Cell Metab
, vol.14
, pp. 804-810
-
-
Sunny, N.E.1
Parks, E.J.2
Browning, J.D.3
Burgess, S.C.4
-
85
-
-
84903144240
-
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
-
Armstrong, M.J.; Hazlehurst, J.M.; Hull, D.; Guo, K.; Borrows, S.; Yu, J.; Gough, S.C.; Newsome, P.N.; Tomlinson, J.W. Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis. Diabetes Obes. Metab. 2014, 16, 651–660.
-
(2014)
Diabetes Obes. Metab
, vol.16
, pp. 651-660
-
-
Armstrong, M.J.1
Hazlehurst, J.M.2
Hull, D.3
Guo, K.4
Borrows, S.5
Yu, J.6
Gough, S.C.7
Newsome, P.N.8
Tomlinson, J.W.9
-
86
-
-
84886558949
-
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
-
Kawano, Y.; Cohen, D.E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J. Gastroenterol. 2013, 48, 434–441.
-
(2013)
J. Gastroenterol
, vol.48
, pp. 434-441
-
-
Kawano, Y.1
Cohen, D.E.2
-
87
-
-
67349268828
-
Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content
-
Pardina, E.; Baena-Fustegueras, J.A.; Catalan, R.; Galard, R.; Lecube, A.; Fort, J.M.; Allende, H.; Vargas, V.; Peinado-Onsurbe, J. Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content. Obes. Surg. 2008, 19, 894–904.
-
(2008)
Obes. Surg
, vol.19
, pp. 894-904
-
-
Pardina, E.1
Baena-Fustegueras, J.A.2
Catalan, R.3
Galard, R.4
Lecube, A.5
Fort, J.M.6
Allende, H.7
Vargas, V.8
Peinado-Onsurbe, J.9
-
88
-
-
35748972366
-
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects
-
Westerbacka, J.; Kolak, M.; Kiviluoto, T.; Arkkila, P.; Siren, J.; Hamsten, A.; Fisher, R.M.; Yki-Jarvinen, H. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007, 56, 2759–2765.
-
(2007)
Diabetes
, vol.56
, pp. 2759-2765
-
-
Westerbacka, J.1
Kolak, M.2
Kiviluoto, T.3
Arkkila, P.4
Siren, J.5
Hamsten, A.6
Fisher, R.M.7
Yki-Jarvinen, H.8
-
89
-
-
45849118669
-
Gene expression in human nafld
-
Greco, D.; Kotronen, A.; Westerbacka, J.; Puig, O.; Arkkila, P.; Kiviluoto, T.; Laitinen, S.; Kolak, M.; Fisher, R.M.; Hamsten, A., et al. Gene expression in human nafld. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G1281–G1287.
-
(2008)
Am. J. Physiol. Gastrointest. Liver Physiol
, vol.294
, pp. G1281-G1287
-
-
Greco, D.1
Kotronen, A.2
Westerbacka, J.3
Puig, O.4
Arkkila, P.5
Kiviluoto, T.6
Laitinen, S.7
Kolak, M.8
Fisher, R.M.9
Hamsten, A.10
-
90
-
-
80052596785
-
Hepatic fatty acid translocase cd36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis c
-
Miquilena-Colina, M.E.; Lima-Cabello, E.; Sanchez-Campos, S.; Garcia-Mediavilla, M.V.; Fernandez-Bermejo, M.; Lozano-Rodriguez, T.; Vargas-Castrillon, J.; Buque, X.; Ochoa, B.; Aspichueta, P. et al. Hepatic fatty acid translocase cd36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis c. Gut 2011, 60, 1394–1402.
-
(2011)
Gut
, vol.60
, pp. 1394-1402
-
-
Miquilena-Colina, M.E.1
Lima-Cabello, E.2
Sanchez-Campos, S.3
Garcia-Mediavilla, M.V.4
Fernandez-Bermejo, M.5
Lozano-Rodriguez, T.6
Vargas-Castrillon, J.7
Buque, X.8
Ochoa, B.9
Aspichueta, P.10
-
91
-
-
84914178553
-
Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease
-
Auguet, T.; Berlanga, A.; Guiu-Jurado, E.; Martinez, S.; Porras, J.A.; Aragones, G.; Sabench, F.; Hernandez, M.; Aguilar, C.; Sirvent, J.J. et al. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease. Int. J. Mol. Sci. 2014, 15, 22173–22187.
-
(2014)
Int. J. Mol. Sci.
, vol.15
, pp. 22173-22187
-
-
Auguet, T.1
Berlanga, A.2
Guiu-Jurado, E.3
Martinez, S.4
Porras, J.A.5
Aragones, G.6
Sabench, F.7
Hernandez, M.8
Aguilar, C.9
Sirvent, J.J.10
-
92
-
-
84902551389
-
De novo lipogenesis in health and disease
-
Ameer, F.; Scandiuzzi, L.; Hasnain, S.; Kalbacher, H.; Zaidi, N. De novo lipogenesis in health and disease. Metabolism 2014, 63, 895–902.
-
(2014)
Metabolism
, vol.63
, pp. 895-902
-
-
Ameer, F.1
Scandiuzzi, L.2
Hasnain, S.3
Kalbacher, H.4
Zaidi, N.5
-
93
-
-
0029846701
-
Regulation of hepatic de novo lipogenesis in humans
-
Hellerstein, M.K.; Schwarz, J.M.; Neese, R.A. Regulation of hepatic de novo lipogenesis in humans. Annu. Rev. Nutr. 1996, 16, 523–557.
-
(1996)
Annu. Rev. Nutr
, vol.16
, pp. 523-557
-
-
Hellerstein, M.K.1
Schwarz, J.M.2
Neese, R.A.3
-
94
-
-
84874600898
-
De novo lipogenesis in human fat and liver is linked to chrebp-beta and metabolic health
-
Eissing, L.; Scherer, T.; Todter, K.; Knippschild, U.; Greve, J.W.; Buurman, W.A.; Pinnschmidt, H.O.; Rensen, S.S.; Wolf, A.M.; Bartelt, A. et al. De novo lipogenesis in human fat and liver is linked to chrebp-beta and metabolic health. Nat. Commun. 2013, 4, 1528.
-
(2013)
Nat. Commun
, vol.4
, pp. 1528
-
-
Eissing, L.1
Scherer, T.2
Todter, K.3
Knippschild, U.4
Greve, J.W.5
Buurman, W.A.6
Pinnschmidt, H.O.7
Rensen, S.S.8
Wolf, A.M.9
Bartelt, A.10
-
95
-
-
0344874201
-
Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease
-
Diraison, F.; Moulin, P.; Beylot, M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 2003, 29, 478–485.
-
(2003)
Diabetes Metab
, vol.29
, pp. 478-485
-
-
Diraison, F.1
Moulin, P.2
Beylot, M.3
-
96
-
-
33646035836
-
Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states
-
Barrows, B.R.; Parks, E.J. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 2006, 91, 1446–1452.
-
(2006)
J. Clin. Endocrinol. Metab.
, vol.91
, pp. 1446-1452
-
-
Barrows, B.R.1
Parks, E.J.2
-
97
-
-
18244382304
-
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
-
Donnelly, K.L.; Smith, C.I.; Schwarzenberg, S.J.; Jessurun, J.; Boldt, M.D.; Parks, E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Investig. 2005, 115, 1343–1351.
-
(2005)
J. Clin. Investig.
, vol.115
, pp. 1343-1351
-
-
Donnelly, K.L.1
Smith, C.I.2
Schwarzenberg, S.J.3
Jessurun, J.4
Boldt, M.D.5
Parks, E.J.6
-
98
-
-
84919626918
-
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
-
Lee, J.J.; Lambert, J.E.; Hovhannisyan, Y.; Ramos-Roman, M.A.; Trombold, J.R.; Wagner, D.A.; Parks, E.J. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. Am. J. Clin. Nutr. 2015, 101, 34–43.
-
(2015)
Am. J. Clin. Nutr.
, vol.101
, pp. 34-43
-
-
Lee, J.J.1
Lambert, J.E.2
Hovhannisyan, Y.3
Ramos-Roman, M.A.4
Trombold, J.R.5
Wagner, D.A.6
Parks, E.J.7
-
99
-
-
29244465372
-
Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease
-
Nakamuta, M.; Kohjima, M.; Morizono, S.; Kotoh, K.; Yoshimoto, T.; Miyagi, I.; Enjoji, M. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 2005, 16, 631–635.
-
(2005)
Int. J. Mol. Med
, vol.16
, pp. 631-635
-
-
Nakamuta, M.1
Kohjima, M.2
Morizono, S.3
Kotoh, K.4
Yoshimoto, T.5
Miyagi, I.6
Enjoji, M.7
-
100
-
-
35148881190
-
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease
-
Kohjima, M.; Enjoji, M.; Higuchi, N.; Kato, M.; Kotoh, K.; Yoshimoto, T.; Fujino, T.; Yada, M.; Yada, R.; Harada, N. et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 2007, 20, 351–358.
-
(2007)
Int. J. Mol. Med.
, vol.20
, pp. 351-358
-
-
Kohjima, M.1
Enjoji, M.2
Higuchi, N.3
Kato, M.4
Kotoh, K.5
Yoshimoto, T.6
Fujino, T.7
Yada, M.8
Yada, R.9
Harada, N.10
-
101
-
-
59149104628
-
The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease
-
Nakamuta, M.; Kohjima, M.; Higuchi, N.; Kato, M.; Kotoh, K.; Yoshimoto, T.; Yada, M.; Yada, R.; Takemoto, R.; Fukuizumi, K. et al. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Int. J. Mol. Med. 2008, 22, 663–667.
-
(2008)
Int. J. Mol. Med.
, vol.22
, pp. 663-667
-
-
Nakamuta, M.1
Kohjima, M.2
Higuchi, N.3
Kato, M.4
Kotoh, K.5
Yoshimoto, T.6
Yada, M.7
Yada, R.8
Takemoto, R.9
Fukuizumi, K.10
-
102
-
-
13744263104
-
Temporal pattern of de novo lipogenesis in the postprandial state in healthy men
-
Timlin, M.T.; Parks, E.J. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. Am. J. Clin. Nutr. 2005, 81, 35–42.
-
(2005)
Am. J. Clin. Nutr
, vol.81
, pp. 35-42
-
-
Timlin, M.T.1
Parks, E.J.2
-
103
-
-
84870389895
-
Does fructose consumption contribute to non-alcoholic fatty liver disease
-
Tappy, L.; Le, K.A. Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin. Res. Hepatol. Gastroenterol. 2012, 36, 554–560.
-
(2012)
Clin. Res. Hepatol. Gastroenterol
, vol.36
, pp. 554-560
-
-
Tappy, L.1
Le, K.A.2
-
104
-
-
84916940992
-
The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease
-
Moore, J.B.; Gunn, P.J.; Fielding, B.A. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. Nutrients 2014, 6, 5679–5703.
-
(2014)
Nutrients
, vol.6
, pp. 5679-5703
-
-
Moore, J.B.1
Gunn, P.J.2
Fielding, B.A.3
-
105
-
-
84907334403
-
Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: A systematic review and meta-analysis
-
Chung, M.; Ma, J.; Patel, K.; Berger, S.; Lau, J.; Lichtenstein, A.H. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2014, 100, 833–849.
-
(2014)
Am. J. Clin. Nutr
, vol.100
, pp. 833-849
-
-
Chung, M.1
Ma, J.2
Patel, K.3
Berger, S.4
Lau, J.5
Lichtenstein, A.H.6
-
106
-
-
84929347096
-
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to pnpla3 sequence variant
-
Margherita Mancina, R.; Matikainen, N.; Maglio, C.; Soderlund, S.; Lundbom, N.; Hakkarainen, A.; Rametta, R.; Mozzi, E.; Fargion, S.; Valenti, L. et al. Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to pnpla3 sequence variant. J. Clin. Endocrinol. Metab. 2015, doi:10.1210/jc.2014-4464.
-
(2015)
J. Clin. Endocrinol. Metab
-
-
Margherita Mancina, R.1
Matikainen, N.2
Maglio, C.3
Soderlund, S.4
Lundbom, N.5
Hakkarainen, A.6
Rametta, R.7
Mozzi, E.8
Fargion, S.9
Valenti, L.10
-
107
-
-
0031985319
-
Hepatic energy and substrate metabolism: A possible metabolic basis for early nutritional support in cirrhotic patients
-
Muller, M.J. Hepatic energy and substrate metabolism: A possible metabolic basis for early nutritional support in cirrhotic patients. Nutrition 1998, 14, 30–38.
-
(1998)
Nutrition
, vol.14
, pp. 30-38
-
-
Muller, M.J.1
-
108
-
-
78651082310
-
Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans
-
Wanders, R.J.; Komen, J.; Kemp, S. Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans. FEBS J. 2011, 278, 182–194.
-
(2011)
FEBS J
, vol.278
, pp. 182-194
-
-
Wanders, R.J.1
Komen, J.2
Kemp, S.3
-
109
-
-
0024503204
-
Foster, D.W. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab
-
McGarry, J.D.; Woeltje, K.F.; Kuwajima, M.; Foster, D.W. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab. Rev. 1989, 5, 271–284.
-
(1989)
Rev
, vol.5
, pp. 271-284
-
-
McGarry, J.D.1
Woeltje, K.F.2
Kuwajima, M.3
-
110
-
-
77953680148
-
Mitochondria and energy formation
-
3rd ed.; Rodés, J., Benhamou, J.-P., Blei, A.T., Reichen, J., Rizzetto, M., Eds.; Blackwell Publishing: Malden, MA, USA
-
Pessayre, D. Mitochondria and energy formation. In Textbook of Hepatology: From Basic Science to Clinical Practice, 3rd ed.; Rodés, J., Benhamou, J.-P., Blei, A.T., Reichen, J., Rizzetto, M., Eds.; Blackwell Publishing: Malden, MA, USA, 2007; pp. 149–165.
-
(2007)
Textbook of Hepatology: From Basic Science to Clinical Practice
, pp. 149-165
-
-
Pessayre, D.1
-
111
-
-
0018864840
-
Regulation of hepatic fatty acid oxidation and ketone body production
-
McGarry, J.D.; Foster, D.W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem. 1980, 49, 395–420.
-
(1980)
Annu. Rev. Biochem.
, vol.49
, pp. 395-420
-
-
McGarry, J.D.1
Foster, D.W.2
-
112
-
-
0030765371
-
Enzymes of ketone body utilization in human tissues: Protein and messenger rna levels of succinyl-coenzyme a (coa):3-ketoacid coa transferase and mitochondrial and cytosolic acetoacetyl-coa thiolases
-
Fukao, T.; Song, X.Q.; Mitchell, G.A.; Yamaguchi, S.; Sukegawa, K.; Orii, T.; Kondo, N. Enzymes of ketone body utilization in human tissues: Protein and messenger rna levels of succinyl-coenzyme a (coa):3-ketoacid coa transferase and mitochondrial and cytosolic acetoacetyl-coa thiolases. Pediatr. Res. 1997, 42, 498–502.
-
(1997)
Pediatr. Res
, vol.42
, pp. 498-502
-
-
Fukao, T.1
Song, X.Q.2
Mitchell, G.A.3
Yamaguchi, S.4
Sukegawa, K.5
Orii, T.6
Kondo, N.7
-
113
-
-
0014972144
-
Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues
-
Williamson, D.H.; Bates, M.W.; Page, M.A.; Krebs, H.A. Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem. J. 1971, 121, 41–47.
-
(1971)
Biochem. J
, vol.121
, pp. 41-47
-
-
Williamson, D.H.1
Bates, M.W.2
Page, M.A.3
Krebs, H.A.4
-
114
-
-
0036154857
-
Control of mitochondrial beta-oxidation flux
-
Eaton, S. Control of mitochondrial beta-oxidation flux. Prog. Lipid Res. 2002, 41, 197–239.
-
(2002)
Prog. Lipid Res
, vol.41
, pp. 197-239
-
-
Eaton, S.1
-
115
-
-
0017738601
-
A possible role for malonyl-coa in the regulation of hepatic fatty acid oxidation and ketogenesis
-
McGarry, J.D.; Mannaerts, G.P.; Foster, D.W. A possible role for malonyl-coa in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Clin. Investig. 1977, 60, 265–270.
-
(1977)
J. Clin. Investig.
, vol.60
, pp. 265-270
-
-
McGarry, J.D.1
Mannaerts, G.P.2
Foster, D.W.3
-
116
-
-
84885466792
-
Theoretical study of lipid accumulation in the liver—Implications for nonalcoholic fatty liver disease
-
Schleicher, J.; Guthke, R.; Dahmen, U.; Dirsch, O.; Holzhuetter, H.G.; Schuster, S. A theoretical study of lipid accumulation in the liver—Implications for nonalcoholic fatty liver disease. Biochim. Biophys. Acta 2013, 1841, 62–69.
-
(2013)
Biochim. Biophys. Acta
, vol.1841
, pp. 62-69
-
-
Schleicher, J.1
Guthke, R.2
Dahmen, U.3
Dirsch, O.4
Holzhuetter, H.G.5
Schuster, S.A.6
-
117
-
-
36749082168
-
Mitochondrial dysfunction due to long-chain acyl-coa dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance
-
Zhang, D.; Liu, Z.X.; Choi, C.S.; Tian, L.; Kibbey, R.; Dong, J.; Cline, G.W.; Wood, P.A.; Shulman, G.I. Mitochondrial dysfunction due to long-chain acyl-coa dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc. Natl. Acad. Sci. USA 2007, 104, 17075–17080.
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 17075-17080
-
-
Zhang, D.1
Liu, Z.X.2
Choi, C.S.3
Tian, L.4
Kibbey, R.5
Dong, J.6
Cline, G.W.7
Wood, P.A.8
Shulman, G.I.9
-
118
-
-
21044438592
-
Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance
-
Ibdah, J.A.; Perlegas, P.; Zhao, Y.; Angdisen, J.; Borgerink, H.; Shadoan, M.K.; Wagner, J.D.; Matern, D.; Rinaldo, P.; Cline, J.M. Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 2005, 128, 1381–1390.
-
(2005)
Gastroenterology
, vol.128
, pp. 1381-1390
-
-
Ibdah, J.A.1
Perlegas, P.2
Zhao, Y.3
Angdisen, J.4
Borgerink, H.5
Shadoan, M.K.6
Wagner, J.D.7
Matern, D.8
Rinaldo, P.9
Cline, J.M.10
-
119
-
-
0041302377
-
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
-
Xu, A.; Wang, Y.; Keshaw, H.; Xu, L.Y.; Lam, K.S.; Cooper, G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Investig. 2003, 112, 91–100.
-
(2003)
J. Clin. Investig
, vol.112
, pp. 91-100
-
-
Xu, A.1
Wang, Y.2
Keshaw, H.3
Xu, L.Y.4
Lam, K.S.5
Cooper, G.J.6
-
120
-
-
37249059359
-
Ppar agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes
-
Seo, Y.S.; Kim, J.H.; Jo, N.Y.; Choi, K.M.; Baik, S.H.; Park, J.J.; Kim, J.S.; Byun, K.S.; Bak, Y.T.; Lee, C.H. et al. Ppar agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes. J. Gastroenterol. Hepatol. 2008, 23, 102–109.
-
(2008)
J. Gastroenterol. Hepatol.
, vol.23
, pp. 102-109
-
-
Seo, Y.S.1
Kim, J.H.2
Jo, N.Y.3
Choi, K.M.4
Baik, S.H.5
Park, J.J.6
Kim, J.S.7
Byun, K.S.8
Bak, Y.T.9
Lee, C.H.10
-
121
-
-
45549089456
-
Moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels
-
Stefanovic-Racic, M.; Perdomo, G.; Mantell, B.S.; Sipula, I.J.; Brown, N.F.; O’Doherty, R.M. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E969–E977.
-
(2008)
Am. J. Physiol. Endocrinol. Metab
, vol.294
, pp. E969-E977
-
-
Stefanovic-Racic, M.1
Perdomo, G.2
Mantell, B.S.3
Sipula, I.J.4
Brown, N.F.5
O’Doherty, R.6
-
122
-
-
33644654777
-
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-coa carboxylases 1 and 2
-
Savage, D.B.; Choi, C.S.; Samuel, V.T.; Liu, Z.X.; Zhang, D.; Wang, A.; Zhang, X.M.; Cline, G.W.; Yu, X.X.; Geisler, J.G. et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-coa carboxylases 1 and 2. J. Clin. Investig. 2006, 116, 817–824.
-
(2006)
J. Clin. Investig.
, vol.116
, pp. 817-824
-
-
Savage, D.B.1
Choi, C.S.2
Samuel, V.T.3
Liu, Z.X.4
Zhang, D.5
Wang, A.6
Zhang, X.M.7
Cline, G.W.8
Yu, X.X.9
Geisler, J.G.10
-
123
-
-
84907782649
-
Creatine reduces hepatic tg accumulation in hepatocytes by stimulating fatty acid oxidation
-
Da Silva, R.P.; Kelly, K.B.; Leonard, K.A.; Jacobs, R.L. Creatine reduces hepatic tg accumulation in hepatocytes by stimulating fatty acid oxidation. Biochim. Biophys. Acta 2014, 1841, 1639–1646.
-
(2014)
Biochim. Biophys. Acta
, vol.1841
, pp. 1639-1646
-
-
Da Silva, R.P.1
Kelly, K.B.2
Leonard, K.A.3
Jacobs, R.L.4
-
124
-
-
0037369729
-
Hepatic cytochrome p450 2e1 activity in nondiabetic patients with nonalcoholic steatohepatitis
-
Chalasani, N.; Gorski, J.C.; Asghar, M.S.; Asghar, A.; Foresman, B.; Hall, S.D.; Crabb, D.W. Hepatic cytochrome p450 2e1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003, 37, 544–550.
-
(2003)
Hepatology
, vol.37
, pp. 544-550
-
-
Chalasani, N.1
Gorski, J.C.2
Asghar, M.S.3
Asghar, A.4
Foresman, B.5
Hall, S.D.6
Crabb, D.W.7
-
125
-
-
70449698539
-
Liver fat and lipid oxidation in humans
-
Kotronen, A.; Seppala-Lindroos, A.; Vehkavaara, S.; Bergholm, R.; Frayn, K.N.; Fielding, B.A.; Yki-Jarvinen, H. Liver fat and lipid oxidation in humans. Liver Int. 2009, 29, 1439–1446.
-
(2009)
Liver Int
, vol.29
, pp. 1439-1446
-
-
Kotronen, A.1
Seppala-Lindroos, A.2
Vehkavaara, S.3
Bergholm, R.4
Frayn, K.N.5
Fielding, B.A.6
Yki-Jarvinen, H.7
-
126
-
-
0014670579
-
Control mechanisms of gluconeogenesis and ketogenesis. Ii. Interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver
-
Williamson, J.R.; Scholz, R.; Browning, E.T. Control mechanisms of gluconeogenesis and ketogenesis. Ii. Interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver. J. Biol. Chem. 1969, 244, 4617–4627.
-
(1969)
J. Biol. Chem
, vol.244
, pp. 4617-4627
-
-
Williamson, J.R.1
Scholz, R.2
Browning, E.T.3
-
127
-
-
84915820736
-
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia
-
Cotter, D.G.; Ercal, B.; Huang, X.; Leid, J.M.; d’Avignon, D.A.; Graham, M.J.; Dietzen, D.J.; Brunt, E.M.; Patti, G.J.; Crawford, P.A. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. J. Clin. Investig. 2014, 124, 5175–5190.
-
(2014)
J. Clin. Investig
, vol.124
, pp. 5175-5190
-
-
Cotter, D.G.1
Ercal, B.2
Huang, X.3
Leid, J.M.4
D’Avignon, D.A.5
Graham, M.J.6
Dietzen, D.J.7
Brunt, E.M.8
Patti, G.J.9
Crawford, P.A.10
-
128
-
-
0033198978
-
Mitochondrial abnormalities in non-alcoholic steatohepatitis
-
Caldwell, S.H.; Swerdlow, R.H.; Khan, E.M.; Iezzoni, J.C.; Hespenheide, E.E.; Parks, J.K.; Parker, W.D., Jr. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J. Hepatol. 1999, 31, 430–434.
-
(1999)
J. Hepatol
, vol.31
, pp. 430-434
-
-
Caldwell, S.H.1
Swerdlow, R.H.2
Khan, E.M.3
Iezzoni, J.C.4
Hespenheide, E.E.5
Parks, J.K.6
Parker, W.D.7
-
129
-
-
18144444592
-
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis
-
Perez-Carreras, M.; Del Hoyo, P.; Martin, M.A.; Rubio, J.C.; Martin, A.; Castellano, G.; Colina, F.; Arenas, J.; Solis-Herruzo, J.A. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003, 38, 999–1007.
-
(2003)
Hepatology
, vol.38
, pp. 999-1007
-
-
Perez-Carreras, M.1
Del Hoyo, P.2
Martin, M.A.3
Rubio, J.C.4
Martin, A.5
Castellano, G.6
Colina, F.7
Arenas, J.8
Solis-Herruzo, J.A.9
-
130
-
-
0033520771
-
Alterations in liver atp homeostasis in human nonalcoholic steatohepatitis
-
Cortez-Pinto, H.; Chatham, J.; Chacko, V.P.; Arnold, C.; Rashid, A.; Diehl, A.M. Alterations in liver atp homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA 1999, 282, 1659–1664.
-
(1999)
A Pilot Study. JAMA
, vol.282
, pp. 1659-1664
-
-
Cortez-Pinto, H.1
Chatham, J.2
Chacko, V.P.3
Arnold, C.4
Rashid, A.5
Diehl, A.M.6
-
131
-
-
84963958773
-
Nitzgen, U.; et al. Peroxisomes compensate hepatic lipid overflow in mice with fatty liver. Biochim. Biophys
-
Knebel, B.; Hartwig, S.; Haas, J.; Lehr, S.; Goeddeke, S.; Susanto, F.; Bohne, L.; Jacob, S.; Koellmer, C.; Nitzgen, U.; et al. Peroxisomes compensate hepatic lipid overflow in mice with fatty liver. Biochim. Biophys. Acta 2015, 1851, 965–976.
-
(1851)
Acta
, vol.2015
, pp. 965-976
-
-
Knebel, B.1
Hartwig, S.2
Haas, J.3
Lehr, S.4
Goeddeke, S.5
Susanto, F.6
Bohne, L.7
Jacob, S.8
Koellmer, C.9
-
132
-
-
0035085155
-
Very-low-density lipoprotein assembly and secretion
-
Shelness, G.S.; Sellers, J.A. Very-low-density lipoprotein assembly and secretion. Curr. Opin. Lipidol. 2001, 12, 151–157.
-
(2001)
Curr. Opin. Lipidol
, vol.12
, pp. 151-157
-
-
Shelness, G.S.1
Sellers, J.A.2
-
133
-
-
0024272606
-
Plasma very low density lipoproteins contain a single molecule of apolipoprotein b
-
Elovson, J.; Chatterton, J.E.; Bell, G.T.; Schumaker, V.N.; Reuben, M.A.; Puppione, D.L.; Reeve, J.R., Jr.; Young, N.L. Plasma very low density lipoproteins contain a single molecule of apolipoprotein b. J. Lipid Res. 1988, 29, 1461–1473.
-
(1988)
J. Lipid Res
, vol.29
, pp. 1461-1473
-
-
Elovson, J.1
Chatterton, J.E.2
Bell, G.T.3
Schumaker, V.N.4
Reuben, M.A.5
Puppione, D.L.6
Reeve, J.R.7
Young, N.L.8
-
134
-
-
0032838304
-
Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein b metabolism
-
Packard, C.J. Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein b metabolism. Curr. Opin. Lipidol. 1999, 10, 237–244.
-
(1999)
Curr. Opin. Lipidol
, vol.10
, pp. 237-244
-
-
Packard, C.J.1
-
135
-
-
0030798890
-
Fatty acid regulation of very low density lipoprotein production
-
Lewis, G.F. Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 1997, 8, 146–153.
-
(1997)
Curr. Opin. Lipidol
, vol.8
, pp. 146-153
-
-
Lewis, G.F.1
-
136
-
-
67349083256
-
Basal very low-density lipoprotein metabolism in response to exercise: Mechanisms of hypotriacylglycerolemia
-
Magkos, F. Basal very low-density lipoprotein metabolism in response to exercise: Mechanisms of hypotriacylglycerolemia. Prog. Lipid Res. 2009, doi:10.1016/j.plipres.2009.1002.1003.
-
(2009)
Prog. Lipid Res
-
-
Magkos, F.1
-
137
-
-
66149188094
-
Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo
-
Magkos, F.; Mittendorfer, B. Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo. Clin. Lipidol. 2009, 4, 215–230.
-
(2009)
Clin. Lipidol
, vol.4
, pp. 215-230
-
-
Magkos, F.1
Mittendorfer, B.2
-
138
-
-
2442477510
-
Regulation of hepatic apolipoprotein b-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles
-
Zhang, Y.L.; Hernandez-Ono, A.; Ko, C.; Yasunaga, K.; Huang, L.S.; Ginsberg, H.N. Regulation of hepatic apolipoprotein b-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. J. Biol. Chem. 2004, 279, 19362–19374.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 19362-19374
-
-
Zhang, Y.L.1
Hernandez-Ono, A.2
Ko, C.3
Yasunaga, K.4
Huang, L.S.5
Ginsberg, H.N.6
-
139
-
-
22544480378
-
“New” Hepatic fat activates pparalpha to maintain glucose, lipid, and cholesterol homeostasis
-
Chakravarthy, M.V.; Pan, Z.; Zhu, Y.; Tordjman, K.; Schneider, J.G.; Coleman, T.; Turk, J.; Semenkovich, C.F. “New” Hepatic fat activates pparalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 2005, 1, 309–322.
-
(2005)
Cell Metab.
, vol.1
, pp. 309-322
-
-
Chakravarthy, M.V.1
Pan, Z.2
Zhu, Y.3
Tordjman, K.4
Schneider, J.G.5
Coleman, T.6
Turk, J.7
Semenkovich, C.F.8
-
140
-
-
0038620476
-
Fatty liver in familial hypobetalipoproteinemia: Triglyceride assembly into vldl particles is affected by the extent of hepatic steatosis
-
Schonfeld, G.; Patterson, B.W.; Yablonskiy, D.A.; Tanoli, T.S.; Averna, M.; Elias, N.; Yue, P.; Ackerman, J. Fatty liver in familial hypobetalipoproteinemia: Triglyceride assembly into vldl particles is affected by the extent of hepatic steatosis. J. Lipid Res. 2003, 44, 470–478.
-
(2003)
J. Lipid Res
, vol.44
, pp. 470-478
-
-
Schonfeld, G.1
Patterson, B.W.2
Yablonskiy, D.A.3
Tanoli, T.S.4
Averna, M.5
Elias, N.6
Yue, P.7
Ackerman, J.8
-
141
-
-
33846151732
-
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
-
Cuchel, M.; Bloedon, L.T.; Szapary, P.O.; Kolansky, D.M.; Wolfe, M.L.; Sarkis, A.; Millar, J.S.; Ikewaki, K.; Siegelman, E.S.; Gregg, R.E. et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N. Engl. J. Med. 2007, 356, 148–156.
-
(2007)
N. Engl. J. Med.
, vol.356
, pp. 148-156
-
-
Cuchel, M.1
Bloedon, L.T.2
Szapary, P.O.3
Kolansky, D.M.4
Wolfe, M.L.5
Sarkis, A.6
Millar, J.S.7
Ikewaki, K.8
Siegelman, E.S.9
Gregg, R.E.10
-
142
-
-
0017744318
-
Accumulation of nascent lipoproteins in rat hepatic golgi during induction of fatty liver by orotic acid
-
Sabesin, S.M.; Frase, S.; Ragland, J.B. Accumulation of nascent lipoproteins in rat hepatic golgi during induction of fatty liver by orotic acid. Lab Investig. 1977, 37, 127–135.
-
(1977)
Lab Investig
, vol.37
, pp. 127-135
-
-
Sabesin, S.M.1
Frase, S.2
Ragland, J.B.3
-
143
-
-
84885993664
-
Cd36 deletion reduces vldl secretion, modulates liver prostaglandin levels and exacerbates hepatic steatosis in ob/ob mice
-
Nassir, F.; Adewole, O.L.; Brunt, E.M.; Abumrad, N.A. Cd36 deletion reduces vldl secretion, modulates liver prostaglandin levels and exacerbates hepatic steatosis in ob/ob mice. J. Lipid Res. 2013, 54, 2988–2997.
-
(2013)
J. Lipid Res
, vol.54
, pp. 2988-2997
-
-
Nassir, F.1
Adewole, O.L.2
Brunt, E.M.3
Abumrad, N.A.4
-
144
-
-
33644827082
-
Overproduction of large vldl particles is driven by increased liver fat content in man
-
Adiels, M.; Taskinen, M.R.; Packard, C.; Caslake, M.J.; Soro-Paavonen, A.; Westerbacka, J.; Vehkavaara, S.; Hakkinen, A.; Olofsson, S.O.; Yki-Jarvinen, H. et al. Overproduction of large vldl particles is driven by increased liver fat content in man. Diabetologia 2006, 49, 755–765.
-
(2006)
Diabetologia
, vol.49
, pp. 755-765
-
-
Adiels, M.1
Taskinen, M.R.2
Packard, C.3
Caslake, M.J.4
Soro-Paavonen, A.5
Westerbacka, J.6
Vehkavaara, S.7
Hakkinen, A.8
Olofsson, S.O.9
Yki-Jarvinen, H.10
-
145
-
-
77951456827
-
Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein b-100 in obesity
-
Chan, D.C.; Watts, G.F.; Gan, S.; Wong, A.T.; Ooi, E.M.; Barrett, P.H. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein b-100 in obesity. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 1043–1050.
-
(2010)
Arterioscler. Thromb. Vasc. Biol
, vol.30
, pp. 1043-1050
-
-
Chan, D.C.1
Watts, G.F.2
Gan, S.3
Wong, A.T.4
Ooi, E.M.5
Barrett, P.H.6
-
146
-
-
0032900336
-
Disruption of ldl receptor gene in transgenic srebp-1a mice unmasks hyperlipidemia resulting from production of lipid-rich vldl
-
Horton, J.D.; Shimano, H.; Hamilton, R.L.; Brown, M.S.; Goldstein, J.L. Disruption of ldl receptor gene in transgenic srebp-1a mice unmasks hyperlipidemia resulting from production of lipid-rich vldl. J. Clin. Investig. 1999, 103, 1067–1076.
-
(1999)
J. Clin. Investig
, vol.103
, pp. 1067-1076
-
-
Horton, J.D.1
Shimano, H.2
Hamilton, R.L.3
Brown, M.S.4
Goldstein, J.L.5
-
147
-
-
84901759008
-
Ixeris
-
Lee, M.R.; Lee, H.Y.; Lee, G.H.; Kim, H.K.; Kim, N.Y.; Kim, S.H.; Kim, H.R.; Chae, H.J. Ixeris dentata decreases er stress and hepatic lipid accumulation through regulation of apob secretion. Am. J. Chin. Med. 2014, 42, 639–649.
-
(2014)
Am. J. Chin. Med
, vol.42
, pp. 639-649
-
-
Lee, M.R.1
Lee, H.Y.2
Lee, G.H.3
Kim, H.K.4
Kim, N.Y.5
Kim, S.H.6
Kim, H.R.7
Chae, H.J.8
-
148
-
-
20544452809
-
Relation between liver fat content and
-
Badaloo, A.; Reid, M.; Soares, D.; Forrester, T.; Jahoor, F. Relation between liver fat content and the rate of vldl apolipoprotein b-100 synthesis in children with protein-energy malnutrition. Am. J. Clin. Nutr. 2005, 81, 1126–1132.
-
(2005)
Am. J. Clin. Nutr
, vol.81
, pp. 1126-1132
-
-
Badaloo, A.1
Reid, M.2
Soares, D.3
Forrester, T.4
Jahoor, F.5
-
149
-
-
0027531667
-
Regulation of hepatic secretion of apolipoprotein b-containing lipoproteins: Information obtained from cultured liver cells
-
Dixon, J.L.; Ginsberg, H.N. Regulation of hepatic secretion of apolipoprotein b-containing lipoproteins: Information obtained from cultured liver cells. J. Lipid Res. 1993, 34, 167–179.
-
(1993)
J. Lipid Res
, vol.34
, pp. 167-179
-
-
Dixon, J.L.1
Ginsberg, H.N.2
-
150
-
-
80051815847
-
Different fatty acids inhibit apob100 secretion by different pathways: Unique roles for er stress, ceramide, and autophagy
-
Caviglia, J.M.; Gayet, C.; Ota, T.; Hernandez-Ono, A.; Conlon, D.M.; Jiang, H.; Fisher, E.A.; Ginsberg, H.N. Different fatty acids inhibit apob100 secretion by different pathways: Unique roles for er stress, ceramide, and autophagy. J. Lipid Res. 2011, 52, 1636–1651.
-
(2011)
J. Lipid Res
, vol.52
, pp. 1636-1651
-
-
Caviglia, J.M.1
Gayet, C.2
Ota, T.3
Hernandez-Ono, A.4
Conlon, D.M.5
Jiang, H.6
Fisher, E.A.7
Ginsberg, H.N.8
-
151
-
-
38149136598
-
Inhibition of apolipoprotein b100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents
-
Ota, T.; Gayet, C.; Ginsberg, H.N. Inhibition of apolipoprotein b100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J. Clin. Investig. 2008, 118, 316–332.
-
(2008)
J. Clin. Investig
, vol.118
, pp. 316-332
-
-
Ota, T.1
Gayet, C.2
Ginsberg, H.N.3
-
152
-
-
85027927359
-
Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction
-
Magkos, F.; Fabbrini, E.; Mohammed, B.S.; Patterson, B.W.; Klein, S. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity (Silver Spring) 2010, 18, 1510–1515.
-
(2010)
Obesity (Silver Spring)
, vol.18
, pp. 1510-1515
-
-
Magkos, F.1
Fabbrini, E.2
Mohammed, B.S.3
Patterson, B.W.4
Klein, S.5
-
153
-
-
84925362378
-
Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease
-
Oh, S.; Shida, T.; Yamagishi, K.; Tanaka, K.; So, R.; Tsujimoto, T.; Shoda, J. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study. Hepatology 2015, 61, 1205–1215.
-
(2015)
A Retrospective Study. Hepatology
, vol.61
, pp. 1205-1215
-
-
Oh, S.1
Shida, T.2
Yamagishi, K.3
Tanaka, K.4
So, R.5
Tsujimoto, T.6
Shoda, J.7
|